RankAlpha logo
Back to Rankings

ATYR

aTyrF
Nasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-07-21
View Chart
+
Peers tracked
8
U.S. public peers
Grade Position
Below peers
vs peer average
ATYR vs peer average
40/100
ATYR vs. peer average (F vs. D)
Grade spread
C 1 · D 3 · F 4
Graded peers loaded
Coverage
8 graded
100% of tracked

Peer overview

MREO is the first available peer comparator.

Same sector: Pharmaceuticals, Biotechnology & Life Sciences · Cap $48.72M

✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
Top peerMREOMereo BioPharma Group
ATYR
aTyr
MREO
Mereo BioPharma Group
Grade
F
C
Momentum
8
91
Value
59
41
Sentiment
-
31
Setup Bias
Net —
-
Market Cap
-
-
Posture
Defensive
Mixed
Open Side-by-Side ComparisonCompare all

Grade position vs MREO

ATYR / MREO
Grade Position
Below peers
ATYR vs. peer average (F vs. D)
40/100
Momentum
8
MREO
Value
59
ATYR
Sentiment
-
-

Rotation landscape

Peers ranked by the order returned from the peer source, with grades from the API.

Rank
Ticker
Company
Grade
Grade score
vs ATYR
1
MREO
Mereo BioPharma Group plc ADR
C
60/100
-2
2
DWTX
Dogwood Therapeutics Inc Common
F
20/100
Even
3
RADX
Radiopharm Theranostics Ltd ADR
F
20/100
Even
4
TIL
Instil Bio Inc Common
F
20/100
Even
5
FLNA
Filana Therapeutics Inc Common
F
20/100
Even
MREO is the first peer returned for this comparison set.